Arcus Biosciences RCUS
$15.62 −$0.16 (-1.01%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $15.50 -0.77%
Open$15.66
Prev close$15.78
Day range$15.56 – $16.66
Volume1.67M
Market cap$2.25B
P/E (TTM)–
Dividend yield–
RCUS Stock News
Headlines matching Arcus Biosciences or the RCUS ticker, most recent first.
- Truist Financial Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Announces Target Price $40
- Wedbush Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $43
- LifeSci Capital Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $46
- H.C. Wainwright Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $45
- Analysts Are Bullish on Top Healthcare Stocks: Arcus Biosciences (RCUS), Prime Medicine, Inc. (PRME) Positive
- TD Cowen Initiates Arcus Biosciences(RCUS.US) With Buy Rating
- Citi Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $45
- Goldman Sachs Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Raises Target Price to $42 Positive
- A Quick Look at Today's Ratings for Arcus Biosciences(RCUS.US), With a Forecast Between $42 to $45
- BofA Securities Maintains Arcus Biosciences(RCUS.US) With Hold Rating, Raises Target Price to $29 Positive
- Goldman Sachs Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $42
- Wedbush Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $41
- Truist Financial Maintains Arcus Biosciences(RCUS.US) With Buy Rating
- H.C. Wainwright Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Raises Target Price to $45 Positive
- LifeSci Capital Initiates Arcus Biosciences(RCUS.US) With Buy Rating, Announces Target Price $46
No comments yet — be the first to weigh in on RCUS.
Sign in to join the discussion.